Created at 4:01 a.m. May, 11, 2024
Author: ankalifa
Co-authors: yelbardisi , andrewmathias8
Related Note: 1484686704568 4
Rationale for change

"The first-generation antipsychotics haloperidol and pimozide are approved by the Food and Drug Administration for the treatment of Tourette syndrome. However, second-generation antipsychotics (eg, risperidone, aripiprazole) are well studied and increasingly preferred in children due to their favorable side effect profile. Other treatments for Tourette syndrome include alpha-2 adrenergic agonists, tetrabenazine, and habit reversal therapy."

Removed redundancy in cloze from first suggestion
Source: UWorld - Step 3 6183

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step3_v12::#UWorld::6183 #AK_Step1_v12::#Physeo::07_Psychiatry::02_Psychiatry::03_Childhood_&_Early_Onset_Disorders #AK_Step2_v12::#NBME #AK_Step2_v12::#B&B::12_Pediatrics::03_Other::03_Child_Psychiatry::Extra #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry::Pediatric_Psychiatry::Neurodevelopmental_Disorders #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::13_Typical_Antipsychotics #AK_Step2_v12::#AMBOSS::XH09Kh #AK_Step2_v12::#FirstAid::13_Psych::01_Childhood_and_Adolescent_Disorders::05_Tourette_Syndrome #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Psychiatry_/_Psychology #AK_Step2_v12::#CMS::Psychiatry::Form_03 #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::zanki #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::15_Typical_Antipsychotics #AK_Step2_v12::#UWorld::Step::3375 #AK_Step1_v12::#AMBOSS::FragQN #AK_Step1_v12::^Systems::Psychiatry #AK_Other::Only_Step_1&2_Overlap #AK_Step2_v12::#OME::04_Psychiatry::12_Peds_Neurodevelopmental #AK_Step2_v12::#SketchyPsych::07_Child_&_Adolescent_Psychiatry::05_Tic_Disorders::01_Tourette_Syndrome #AK_Step1_v12::#Bootcamp::Psychiatry::02_Developmental_Disorders::05_Isolating_Developmental_Disorders #AK_Step1_v12::#B&B::19_Psych::02_Pathology::02_Childhood_Disorders #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::06_Antidepressants::*Preferred_Medications_For_Selected_Psychiatric_Conditions #AK_Step1_v12::#NBME::32 #AK_Step1_v12::#Low/HighYield::4-LowerYield #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::UW_Psych #AK_Step2_v12::#UWorld::COMLEX::100181 #AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::03_Childhood_and_early-onset_disorders::11_Tourette_syndrome